Upon ingestion, the new Enzian dosage form resides in the stomach for several hours and steadily delivers drug into the blood. This enables enhanced effectiveness of many life-saving drug therapies.
Earlier this year, Hovione announced a partnership with a Danish firm that has developed a whey protein–based excipient meant to enhance spray-dry dispersions. Hovione saw in Zerion Pharma’s ...
NEW YORK, Oct. 27, 2025 /CNW/ -- The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity and improve patient outcomes. Traditional ...
A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water. For most treatments, the oral route remains the gold ...
Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has secured the #1 global ranking for new U.S. patent families in AI Drug Discovery ...
Hovione has expanded its oral drug delivery toolkit. Working with Zerion Pharma, the company plans to commercialize technology for overcoming the common problem of low drug solubility. Formulations ...
SEATTLE & BETHLEHEM, Pa.--(BUSINESS WIRE)--Spoke Sciences, Inc. (Spoke), an ingredient technology company developing innovative approaches to provide better, safer, and more reliable functional ...
Aegis Awarded Its First Patent for Oral Delivery of Nucleotide-Based Drugs With High Bioavailability
SAN DIEGO, CA--(Marketwired - Feb 5, 2014) - Aegis Therapeutics LLC announced today that it has been awarded its first patent for oral delivery of nucleotide analog based drugs based upon Aegis' ...
Detailed price information for Bionxt Solutions Inc. (BNXT-CN) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results